Sigmak Lifesciences supplies WHO-GMP sourced injectable formulations, active pharmaceutical ingredients, and specialty chemical intermediates to pharmaceutical manufacturers, importers, and distributors in Ghana. Ghana's pharmaceutical sector is governed by the Food and Drugs Authority (FDA Ghana), with an established framework for registration and import of finished dosage forms and raw materials.
The injectable portfolio covers anti-malarials, antibiotics, anti-infectives, analgesics, vitamins, and essential medicines in ampoule, vial, and dry powder formats. Documentation including COA, COPP, stability data, and registration dossiers is available to support FDA Ghana submission requirements.
Ghana's National Health Insurance Scheme (NHIS) drives significant demand for essential medicines procurement. Sigmak supports both private sector customers and government tender participation with structured supply and documentation programs across West Africa.